Cell Therapies

Cell therapies

The Cell Therapies Platform hosts a biological Isolator that provides a sterile, fully contained environment suitable for the processing of human cells and tissue. This facility has been established to boost the clinical development of human cell-based therapies. 

The Cell Therapies Platform provides a flexible, cost-effective alternative to traditional cell therapy manufacturing and regenerative medicine facilities. Available to researchers and commercial entities from within and out with the MHTP seeking to progress cell and tissue based therapies to the clinic. The platform houses the BioSpherix Xvivo GMP Isolator, an enclosed, integrated and fully controlled environment for cell and tissue processing. The Miltenyi MACSQuant Tyto clinical cell sorter and the GeSim BioScaffolder with 3D biological printing and melt electrospinning capabilities.


  • Prof Graham Jenkin, Ritchie Centre, Hudson Institute, Department of Obstetrics and Gynaecology, Monash University, Ph. +61 3 8572 2801, graham.jenkin@monash.edu
  • Dr Gordon McPhee, Cell Therapies Platform Manager, MHTP Translational Research Facility, Ph. +61 3 8572 2802, gordon.mcphee@hudson.org.au